Literature DB >> 16715374

Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.

Harminder Bajaj1, Vikas K Sharma, Advait Badkar, David Zeng, Sandeep Nema, Devendra S Kalonia.   

Abstract

PURPOSE: The purpose of the study was to investigate the relationship of the second virial coefficient, B22, to the extent of irreversible protein aggregation upon storage.
METHODS: A monoclonal antibody and ovalbumin were incubated at 37 degrees C (3 months) under various solution conditions to monitor the extent of aggregation. The B22 values of these proteins were determined under similar solution conditions by a modified method of flow-mode static light scattering. The conformation of these proteins was studied using circular dichroism (CD) spectroscopy and second-derivative Fourier transform infrared spectroscopy.
RESULTS: Both proteins readily aggregated at pH 4.0 (no aggregation observed at pH 7.4); the extent of aggregation varied with the ionic strength and the presence of cosolutes (sucrose, glycine, and Tween 80). Debye plots of the monoclonal antibody showed moderate attractive interactions at pH 7.4, whereas, at pH 4.0, nonlinear plots were obtained, indicating self-association. CD studies showed partially unfolded structure of antibody at pH 4.0 compared with that at pH 7.4. In the case of ovalbumin, similar B22 values were obtained in all solution conditions irrespective of whether the protein aggregated or not. CD studies of ovalbumin indicated the presence of a fraction of completely unfolded as well as partially unfolded species at pH 4.0 compared with that at pH 7.4.
CONCLUSIONS: The formation of a structurally altered state is a must for irreversible aggregation to proceed. Because this aggregation-prone species could be an unfolded species present in a small fraction compared with that of the native state or it could be a partially unfolded state whose net interactions are not significantly different compared with those of the native state, yet the structural changes are sufficient to lead to long-term aggregation, it is unlikely that B22 will correlate with long-term aggregation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715374     DOI: 10.1007/s11095-006-0018-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein.

Authors:  A W Vermeer; W Norde
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Brent S Kendrick; Byeong S Chang; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Temperature- and pH-induced multiple partially unfolded states of recombinant human interferon-alpha2a: possible implications in protein stability.

Authors:  Vikas K Sharma; Devendra S Kalonia
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

4.  The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient.

Authors:  Jason G S Ho; Anton P J Middelberg; Paul Ramage; Hans P Kocher
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

5.  Circumnavigating misfolding traps in the energy landscape through protein engineering: suppression of molten globule and aggregation in carbonic anhydrase.

Authors:  Martin Karlsson; Lars-Göran Mårtensson; Patrik Olofsson; Uno Carlsson
Journal:  Biochemistry       Date:  2004-06-01       Impact factor: 3.162

6.  Molecular origins of osmotic second virial coefficients of proteins.

Authors:  B L Neal; D Asthagiri; A M Lenhoff
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

7.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition.

Authors:  Sampathkumar Krishnan; Eva Y Chi; Jonathan N Webb; Byeong S Chang; Daxian Shan; Merrill Goldenberg; Mark C Manning; Theodore W Randolph; John F Carpenter
Journal:  Biochemistry       Date:  2002-05-21       Impact factor: 3.162

Review 8.  Mutations and off-pathway aggregation of proteins.

Authors:  R Wetzel
Journal:  Trends Biotechnol       Date:  1994-05       Impact factor: 19.536

9.  Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

Authors:  Muppalla Sukumar; Sacha M Storms; Michael R De Felippis
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

10.  Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.

Authors:  Christopher J Roberts; Richard T Darrington; Maureen B Whitley
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

View more
  12 in total

1.  A high-throughput method for detection of protein self-association and second virial coefficient using size-exclusion chromatography through simultaneous measurement of concentration and scattered light intensity.

Authors:  Harminder Bajaj; Vikas K Sharma; Devendra S Kalonia
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

Review 2.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

3.  Aggregation of a multidomain protein: a coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress.

Authors:  Christian Beyschau Andersen; Mauro Manno; Christian Rischel; Matthías Thórólfsson; Vincenzo Martorana
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

4.  High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.

Authors:  Mitja Zidar; Ana Šušterič; Miha Ravnik; Drago Kuzman
Journal:  Pharm Res       Date:  2017-06-07       Impact factor: 4.200

5.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

Review 6.  Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions.

Authors:  Steven B Geng; Jason K Cheung; Chakravarthy Narasimhan; Mohammed Shameem; Peter M Tessier
Journal:  J Pharm Sci       Date:  2014-09-10       Impact factor: 3.534

7.  Identifying protein aggregation mechanisms and quantifying aggregation rates from combined monomer depletion and continuous scattering.

Authors:  Gregory V Barnett; Michael Drenski; Vladimir Razinkov; Wayne F Reed; Christopher J Roberts
Journal:  Anal Biochem       Date:  2016-08-07       Impact factor: 3.365

8.  Selecting temperature for protein crystallization screens using the temperature dependence of the second virial coefficient.

Authors:  Jun Liu; Da-Chuan Yin; Yun-Zhu Guo; Xi-Kai Wang; Si-Xiao Xie; Qin-Qin Lu; Yong-Ming Liu
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

9.  Self-Interaction Chromatography of mAbs: Accurate Measurement of Dead Volumes.

Authors:  S H M Hedberg; J Y Y Heng; D R Williams; J M Liddell
Journal:  Pharm Res       Date:  2015-08-13       Impact factor: 4.200

10.  The second virial coefficient as a predictor of protein aggregation propensity: A self-interaction chromatography study.

Authors:  A Quigley; D R Williams
Journal:  Eur J Pharm Biopharm       Date:  2015-08-07       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.